Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Quote

Not a forecast

“The great results from the interim analysis has changed everything in that we are now actively preparing for FDA approval and commercialization based not on hopes and dreams but on actual data from Phase 3.”
· Psychedelic Pioneer Rick Doblin On FDA Trials Of MDMA: Most Important Reality Check Of MAPS' 34-Year History · article

Forbes piece on the interim analysis (90%+ probability of statistical significance). Doblin frames FDA approval and commercialization as the expected next step.

Descriptive, retrospective, or a statement of preference; no future state asserted.